Omar El Bounkari
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Reverse engineering of BNIP3 identifies a mitochondrial protective peptide.
Journal: Nature communications
Published: August 05, 2025
Circulating cytokine levels and 5-year vascular recurrence after stroke: A multicenter prospective cohort study.
Journal: European stroke journal
Published: March 24, 2025
CCR3-dependent eosinophil recruitment is regulated by sialyltransferase ST3Gal-IV.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 30, 2024
CD74 is a functional MIF receptor on activated CD4+ T cells.
Journal: Cellular and molecular life sciences : CMLS
Published: March 26, 2024
An atypical atherogenic chemokine that promotes advanced atherosclerosis and hepatic lipogenesis.
Journal: Nature communications
Published: January 24, 2024
Rare damaging CCR2 variants are associated with lower lifetime cardiovascular risk.
Journal: medRxiv : the preprint server for health sciences
Published: August 30, 2023
Metabolic reprogramming of immune cells by mitochondrial division inhibitor-1 to prevent post-vascular injury neointimal hyperplasia.
Journal: Atherosclerosis
Published: October 11, 2022
Heterocomplexes between the atypical chemokine MIF and the CXC-motif chemokine CXCL4L1 regulate inflammation and thrombus formation.
Journal: Cellular and molecular life sciences : CMLS
Published: January 28, 2022
Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly.
Journal: Nature communications
Published: January 16, 2022
CXCR4 and CD74 together enhance cell survival in response to macrophage migration-inhibitory factor in chronic lymphocytic leukemia.
Journal: Experimental hematology
Published: July 30, 2021
Last Updated: 09/26/2026